IDEAYA Biosciences (NASDAQ:IDYA) Receives “Overweight” Rating from Cantor Fitzgerald
IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Cantor Fitzgerald in a research note issued on Tuesday,Benzinga reports. A number of other equities research analysts also recently issued reports on IDYA. UBS Group started coverage on IDEAYA Biosciences in a research report on Thursday, October 24th. […]
More Stories
Short Interest in Globant S.A. (NYSE:GLOB) Grows By 8.9%
Globant S.A. (NYSE:GLOB – Get Free Report) was the target of a significant growth in short interest during the month...
Biloxi Marsh Lands (OTCMKTS:BLMC) Issues Earnings Results
Biloxi Marsh Lands (OTCMKTS:BLMC – Get Free Report) issued its earnings results on Tuesday. The energy company reported $0.11 earnings...
Diamondback Energy (NASDAQ:FANG) Price Target Lowered to $232.00 at Piper Sandler
Diamondback Energy (NASDAQ:FANG – Get Free Report) had its price target reduced by analysts at Piper Sandler from $252.00 to...
Serve Robotics (NASDAQ:SERV) Shares Gap Up – Should You Buy?
Serve Robotics Inc. (NASDAQ:SERV – Get Free Report)’s stock price gapped up before the market opened on Tuesday . The...
Brilliant Earth Group, Inc. (NASDAQ:BRLT) Short Interest Down 8.0% in November
Brilliant Earth Group, Inc. (NASDAQ:BRLT – Get Free Report) was the target of a large decrease in short interest during...
Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL) Shares Gap Up – What’s Next?
Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL – Get Free Report)’s stock price gapped up before the market opened on...